AstraZeneca’s Oncology Strategy Yields Victories

Tagrisso Adjuvant Data, Koselugo NF1 Approval Are Signs Of Progress

 
• By Mandy Jackson
  
DNA strand and Cancer Cell Oncology Research Concept 3D rendering
The targeted therapies Tagrisso and selumetinib met key milestones • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip